Condition: Breast Augmentation · Breast Reconstruction · Breast Revision-Augmentation · Sponsor: GCA (Eurosilicone)
The goal of this observational, non-comparative study is to determine the frequency and rate of rupture and capsular contracture Baker III-IV of Eurosilicone Luna range of breast implants, over a 10-year period following surgical implantation in female population between 18 and 65 years old undergoing primary or revision of breast augmentation or breast reconstruction.
This description comes directly from the study's public registry record.
GCA Clinical affairs department · +33 783326098 · luna10PMCF@gcaesthetics.com
Always discuss trial participation with your own doctor first.
| Dr Guillaume Lasserre | Villefranche-sur-Saône, France | Recruiting |
| DScultp Clinic | Barcelona, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07679594